EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Descriptive Analysis of Epidemiology, Demographic Characteristics, and Survival of Dedifferentiated Liposarcoma in France

Julien Bollard iD, Nicolas Penel, Thibaud Valentin, Robin Tranchant, Marie Najean, Christophe Maritaz, Maud Toulmonde iD, Matthieu Faron, Axel Le Cesne, Florence Duffaud, Alice Hervieu, Nelly Firmin and 12 more

International Journal of Cancer · 2026-11-03

DOI: 10.1002/ijc.70747 ↗

At a glance

Journal article in International Journal of Cancer, published online on 2026-11-03. Written by Julien Bollard and 23 co-authors. Institution: Research and Innovation Department, Centre Léon Bérard, Lyon, France. 40 references. The full text is freely available (open access, CC BY 4.0). Funded by: Boehringer Ingelheim France.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Dedifferentiated liposarcoma (DDLPS) is a rare soft tissue sarcoma with limited real‐world epidemiologic data. This nationwide retrospective study describes the epidemiology, management, and outcomes of DDLPS in France using the NETSARC+ national sarcoma registry. A total of 1451 adults with histologically confirmed DDLPS diagnosed between 2010 and 2021 across 14 expert centers were included. The median age at diagnosis was 67 years, with a male predominance (M/F ratio 1.84). The retroperitoneum was the most frequent site (51.6%), and tumors were large (median 150 mm) and FNCLCC Grade 2–3 in 82.6%. MDM2 amplification was confirmed in 97.4% of tested cases. Surgery was performed in 91% of localized cases and was the strongest independent prognostic factor for overall survival (OS). After a median follow‐up of 78.4 months, median OS was 90.3 months (95% CI 82.7–101.0). Among metastatic patients, the median first‐line progression‐free survival (PFS1) was 4.1 months, and second‐line PFS (PFS2) was 3.1 months, with stable disease as the most common best response (40.6%) and 12% of partial response. Doxorubicin‐based chemotherapy remained the predominant systemic treatment but yielded only modest activity, with no difference compared to other regimens in terms of response rate. Independent predictors of improved OS included younger age, smaller tumor size, good performance status, lower grade and absence of metastasis at diagnosis. This large, population‐based study provides the most comprehensive real‐world characterization of DDLPS in France, validating known prognostic factors, emphasizing the central role of surgery, and underscoring the persistent and unmet need for more effective systemic therapies.

Subjects

Author keywords

NETSARC+ networkdedifferentiated liposarcomareal‐word descriptive study

Authors and institutions

  • Research and Innovation Department, Centre Léon Bérard, Lyon, France.
  • Medical Oncology Department, Centre Oscar Lambret, Lille, France.
  • Medical Oncology, Oncopole Claudius Regaud, Toulouse, France.
  • Boehringer-Ingelheim France, Paris, France.
  • Department of Medical Oncology, Institut Bergonié, Bordeaux, France.
  • Sarcoma Unit, Gustave Roussy, Villejuif, France.

ORCID profiles: Julien Bollard, Maud Toulmonde, Jean-Yves Blay, Sarah Watson

Funding

  • Boehringer Ingelheim France

Cite

APA

Bollard, J., Penel, N., Valentin, T., Tranchant, R., Najean, M., Maritaz, C., Toulmonde, M., Faron, M., Le Cesne, A., Duffaud, F., Hervieu, A., Firmin, N., Bompas, E., De Percin, S., Perrin, C., Dubray-Longeras, P., Ryckewaert, T., Ducimetiere, F., Chemin, C., …, & Watson, S. (2026). Descriptive Analysis of Epidemiology, Demographic Characteristics, and Survival of Dedifferentiated Liposarcoma in France. International Journal of Cancer. https://doi.org/10.1002/ijc.70747

Vancouver

Bollard J, Penel N, Valentin T, Tranchant R, Najean M, Maritaz C, et al. Descriptive Analysis of Epidemiology, Demographic Characteristics, and Survival of Dedifferentiated Liposarcoma in France. International Journal of Cancer. 2026. doi:10.1002/ijc.70747

BibTeX
@article{Bollard2026,
  author = {Bollard, Julien and Penel, Nicolas and Valentin, Thibaud and Tranchant, Robin and Najean, Marie and Maritaz, Christophe and Toulmonde, Maud and Faron, Matthieu and Le Cesne, Axel and Duffaud, Florence and Hervieu, Alice and Firmin, Nelly and Bompas, Emmanuelle and De Percin, Sixtine and Perrin, Christophe and Dubray-Longeras, Pascale and Ryckewaert, Thomas and Ducimetiere, Françoise and Chemin, Claire and Bouvier, Christophe and Morelle, Magali and Blay, Jean-Yves and Brahmi, Mehdi and Watson, Sarah},
  title = {Descriptive Analysis of Epidemiology, Demographic Characteristics, and Survival of Dedifferentiated Liposarcoma in France},
  journal = {International Journal of Cancer},
  year = {2026},
  doi = {10.1002/ijc.70747}
}
Start for free →